Center-Authored Papers

Filters: Author is True, Lawrence D  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
No Keywords
True LD, Zhang H, Ye M, Huang C-Y, Nelson PS, von Haller PD, Tjoelker LW, Kim J-S, Qian W-J, Smith RD et al..  2010.  CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 23(10):1346-56. Abstract
2008
Klezovitch O, Risk M, Coleman I, Lucas JM, Null M, True LD, Nelson PS, Vasioukhin VI.  2008.  A causal role for ERG in neoplastic transformation of prostate epithelium.. Proceedings of the National Academy of Sciences of the United States of America. 105(6):2105-10. Abstract
2009
2010
True LD, Zhang H, Ye M, Huang C-Y, Nelson PS, von Haller PD, Tjoelker LW, Kim J-S, Qian W-J, Smith RD et al..  2010.  CD90/THY1 is overexpressed in prostate cancer-associated fibroblasts and could serve as a cancer biomarker.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 23(10):1346-56. Abstract
2011
2013
Mostaghel EA, Nelson PS, Lange P, Lin DW, Taplin ME, Balk S, Ellis W, Kantoff P, Marck B, Tamae D et al..  2014.  Targeted androgen pathway suppression in localized prostate cancer: a pilot study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(3):229-37. Abstract
Ho ME, Quek S-I, True LD, Morrissey C, Corey E, Vessella RL, Dumpit R, Nelson PS, Maresh EL, Mah V et al..  2013.  Prostate cancer cell phenotypes based on AGR2 and CD10 expression.. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 26(6):849-859. Abstract
2014
5-alpha Reductase Inhibitors
ADENOCARCINOMA